Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2

Conditions

Polycythemia Vera 2Myeloproliferative Disorders 2Lung Neoplasms 2Tuberous Sclerosis 1Smoking 1Renal Insufficiency, Chronic 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Cyst 1Non-alcoholic Fatty Liver Disease 1Neoplasms 1Multiple Sclerosis 1Lymphangioleiomyomatosis 1Liver Cirrhosis, Biliary 1Lip Neoplasms 1Irritable Bowel Syndrome 1Inflammatory Bowel Diseases 1Hepatitis 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Gastritis 1Fibrosis 1Exocrine Pancreatic Insufficiency 1Endocrine Gland Neoplasms 1Dyslipidemias 1Diabetes Mellitus 1Cystic Fibrosis 1Crohn Disease 1Chronic Pain 1Chronic Disease 1

Interventions

fludarabine 19Whole-Body Irradiation 18Cyclophosphamide 17fludarabine phosphate 16ruxolitinib 15Mycophenolic Acid 14Specimen Handling 13Tacrolimus 11Azacitidine 11Biopsy 10Peripheral Blood Stem Cell Transplantation 9Melphalan 9Cytarabine 9venetoclax 8Sirolimus 8Busulfan 8Stem Cell Transplantation 6Injections 6Granulocyte Colony-Stimulating Factor 6Daunorubicin 5Cyclosporine 5CPX-351 5luspatercept 4ivosidenib 4itacitinib 4fedratinib 4decitabine and cedazuridine drug combination 4Thiotepa 4Liposomes 4Cyclosporins 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Myeloproliferative Disorders × Phlebotomy × 1 year × Clear all
NCT04182100 2025-09-15

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

PharmaEssentia Japan K.K.

Phase 2 Completed
29 enrolled 15 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera

NCT06290765 2025-07-31

PV

PharmaEssentia

Phase 4 Not yet recruiting
70 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡